NCT07760688 Structured Periprocedural Nursing Interventions in Men Undergoing Transrectal Prostate Biopsy
| NCT ID | NCT07760688 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Mostar |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-08-04 |
| Primary Completion | 2027-07-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2026-08-04 with a primary completion date of 2027-07-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective longitudinal interventional study aims to evaluate the effect of structured peri-procedural nursing interventions on resilience and anxiety in men undergoing transrectal prostate biopsy. Participants will receive a standardized nursing intervention before and after the biopsy procedure. Resilience, anxiety, pain, lower urinary tract symptoms, and perceived nursing support will be assessed at predefined time points. Histopathological findings (benign or malignant) will be used for subgroup analyses. The study is conducted at the University Clinical Hospital Mostar, Bosnia and Herzegovina.
Eligibility Criteria
Inclusion Criteria: * Male participants aged 40 years or older. * Scheduled for transrectal ultrasound-guided prostate biopsy because of suspected prostate cancer. * Able to understand the study procedures and provide written informed consent. * Willing to complete all study assessments during the follow-up period. Exclusion Criteria: * Inabillity to provide informed consent. * Severe cognitive impairment or psychiatric disorder preventing questionnaire completion. * Previous disgnosis of prostate cancer. * Inabillity to complete follow-up assessments. * Withdrawal of informed consent at any time.
Contact & Investigator
Maja Ardjelan, MSc
PRINCIPAL INVESTIGATOR
University of Mostar
Frequently Asked Questions
Who can join the NCT07760688 clinical trial?
This trial is open to male participants only, aged 40 Years or older, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07760688 currently recruiting?
Yes, NCT07760688 is actively recruiting participants. Contact the research team at majaardjelan555@gmail.com for enrollment information.
Where is the NCT07760688 trial being conducted?
This trial is being conducted at Mostar, Bosnia and Herzegovina.
Who is sponsoring the NCT07760688 clinical trial?
NCT07760688 is sponsored by University of Mostar. The principal investigator is Maja Ardjelan, MSc at University of Mostar. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.